Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Diaceutics Share News (DXRX)
DXRX Share
Price
DXRX Share
News
DXRX Share
Chat
DXRX Share
Trades22
DXRX
Live RNS
DXRX Share
Charts
DXRX Level 2
Console
DXRX Live
Share Price
DXRX Broker
Ratings
DXRX Directors
Deals
DXRX Financial
Diary
DXRX
Fundamentals
DXRX Short
Positions
DXRX
Media
DXRX Company
Research
DXRX Company
Timeline
Share Price Information for Diaceutics (DXRX)
Last checked at -
Last checked at 
Intraday Diaceutics Share Chart
Diaceutics News
Diaceutics wins ?1m pharmaceutical client contract
(Sharecast News) - Diagnostic commercialisation company Diaceutics announced a new, "significant" client contract win with an unnamed pharmaceutical c...
Diaceutics builds on strong Q1, trades in line
(Sharecast News) - Diagnostic commercialisation company Diaceutics said on Wednesday that it had built on its good start to the financial year, with t...
UPDATE: Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Launch
UPDATE: Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Launch
Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Platform Launch
Diaceutics Raises Almost GBP21 Million Ahead Of DXRX Platform Launch
Diaceutics raising £20.5m ahead of launch of new platform
(Sharecast News) - Diagnostics commercialisation company Diaceutics has conditionally raised £20.5m before expenses, through a placing of 14,137,...
Diaceutics maintains expectations after first quarter
(Sharecast News) - Diaceutics said it had made a "good start" to the 2020 financial year on Tuesday, with trading in the first quarter in line with th...
Diaceutics flags serious fall in cancer testing amid Covid-19
(Sharecast News) - Precision diagnostics commercialisation company Diaceutics announced research results from its Covid-19 oncology tracker on Wednesd...
Diaceutics Records Profit Fall In 2019 As Expenses Rise
Diaceutics Records Profit Fall In 2019 As Expenses Rise
Follow the stocks
